What is TVTX's current stock price?

As of now, TVTX is trading at $28.27, with a daily change of -2.30%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

TVTX Stock Analysis & IQ Rating | Travere Therapeutics

TVTX

Travere Therapeutics

$28.27

-$0.66 | -2.30%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$42.13

MKT CAP

$2.50B

52W Low

$12.91

VOL

$205.69K

P/E Ratio

N/A

AVG VOL

$2.69M

RSI

29.96

TREND

Sideways

TVTX Stock IQ

Login to see Travere Therapeutics (TVTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

TVTX Target Price

Login to display

Strengths

TVTX Rewards

Earnings are forecast to grow

TVTX Rewards

Upgraded on attractively valued

Technical Indicators

TVTX Technical Indicators

5+ Days Down

TVTX Price Performance

$33.89 (-16.58%)

$27.89 (+1.36%)

$17.92 (+57.76%)

$20.46 (+38.17%)

1year

6month

3month

1month

TVTX Risk Level

TVTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

TVTX Analysts Opinion

TVTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

TVTX Analysts Opinion

TVTX Analysts opinion is negative and it remained unchanged from the past 3 months

TVTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

29%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

11%

100%

TVTX Street Sentiment

TVTX Street Sentiment is unimpressive and have negative views on the near-term outlook

TVTX Performance Sentiment

Sentiments overview associated with TVTX events and the stock performance.

29%

64%

Positive

Negative

4 out of 14
events present

9 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$28.93

Resistance
Price

$28.72

Current Price Range

$40.28

Show methods +

Linked to TVTX

IQ

Close Price

Change

NVS

4.12

142.54

-1.96%

Recently Viewed

Close Price

Change

TVTX

Travere Therapeutics

28.27

-2.30%

WPP

21.69

-1.03%

XPEL

53.97

+2.46%

DSX

Diana Shipping

1.93

+1.32%

AMP

Ameriprise Financial Inc.

515.75

+1.60%

TVTX Latest Analysis +

TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA. Travere Therapeutics shares fall after the FDA extends its review timeline for Filsparis sNDA in FSGS pushing the decision date to April 2026.

Wed Jan 14, 2026

$28.93 | -0.62%

Momentum

Travere Stock Slips After FDA Delays Review Of Key Kidney Drug. ) stock fell Tuesday as the company pressure following a corporate update that raised concerns among investors.The stock’.s decline comes as the broader market is experiencing mixed performance with the S&.P 500 down 0.16% and the Nasdaq slightly up by 0.02%.On Tuesday the United States Food and Drug Administration (FDA) extended the review timeline of The new Prescription Drug User Fee Act (PDUFA) .The extension follows th

Wed Jan 14, 2026

$28.93 | -0.62%

Activity

Earnings

Momentum

Why Travere Therapeutics Stock Got Trounced on Tuesday. Key PointsThe FDA has extended its review of the companys Filspari.

Wed Jan 14, 2026

$28.93 | -0.62%

Momentum

Travere Ligand Hammered On A Surprise Delay For Their Linchpin Drug. Travere Therapeutics shares crashed Tuesday as investors digested a delay for its drug Filspari in treating a kidney disease.The post Travere Ligand Hammered On A Surprise Delay For Their Linchpin Drug appeared first on Investor'.s Business Daily.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere Therapeutics Becomes Oversold (TVTX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Tue Jan 13, 2026

$29.11 | -14.63%

Technical

Noteworthy Tuesday Option Activity: TVTX RDDT LGND. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Travere Therapeutics Inc (Symbol: TVTX) where a total of 40965 contracts have traded so far representing approximately 4.1 million underlying shares. That amounts to

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere Therapeutics Hammered On A Potential Surprise Delay For Filspari. Travere Therapeutics shares crashed Tuesday as investors digested a potential delay for its drug Filspari in treating a kidney disease.The post Travere Therapeutics Hammered On A Potential Surprise Delay For Filspari appeared first on Investor'.s Business Daily.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere stock plunges after FDA requests more data on kidney drug.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

FAQ About TVTX Stock Insights

What is TVTX current stock price?

What are TVTX stock strengths?

What is TVTX Risk Level?

What is TVTX market cap and volume?

What is TVTX current Stock IQ?

Should I buy TVTX stock right now?

Is TVTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for TVTX?

What does a 'Strong Sell' rating mean for TVTX?

What factors influence TVTX's Stock IQ?

Explore our TVTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored TVTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our TVTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

TVTX

Travere Therapeutics

Set Alerts

Current Price

$28.27

-$0.66 | -2.30%

52W High

$42.13

MKT CAP

$2.50B

52W Low

$12.91

VOL

$205.69K

P/E Ratio

N/A

AVG VOL

$2.69M

RSI

29.96

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

TVTX Stock IQ

Login to unlock Travere Therapeutics (TVTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

TVTX Rewards

Earnings are forecast to grow

TVTX Rewards

Upgraded on attractively valued

Technical Indicators

TVTX Technical Indicators

5+ Days Down

Linked to TVTX

Symbol

IQ

Close

Change

NVS

4.12

142.54

-1.96%

TVTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

29%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

11%

100%

TVTX Street Sentiment

TVTX Street Sentiment is unimpressive and have negative views on the near-term outlook

TVTX Risk Level

TVTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

TVTX Performance Sentiment

Sentiments overview associated with TVTX events and the stock performance.

29%

64%

Positive

Negative

4 out of 14
events present

9 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$28.93

Resistance
Price

$28.72

Current Price Range

$40.28

Show methods +

TVTX Latest Analysis

TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA. Travere Therapeutics shares fall after the FDA extends its review timeline for Filsparis sNDA in FSGS pushing the decision date to April 2026.

Wed Jan 14, 2026

$28.93 | -0.62%

Momentum

Travere Stock Slips After FDA Delays Review Of Key Kidney Drug. ) stock fell Tuesday as the company pressure following a corporate update that raised concerns among investors.The stock’.s decline comes as the broader market is experiencing mixed performance with the S&.P 500 down 0.16% and the Nasdaq slightly up by 0.02%.On Tuesday the United States Food and Drug Administration (FDA) extended the review timeline of The new Prescription Drug User Fee Act (PDUFA) .The extension follows th

Wed Jan 14, 2026

$28.93 | -0.62%

Activity

Earnings

Momentum

Why Travere Therapeutics Stock Got Trounced on Tuesday. Key PointsThe FDA has extended its review of the companys Filspari.

Wed Jan 14, 2026

$28.93 | -0.62%

Momentum

Travere Ligand Hammered On A Surprise Delay For Their Linchpin Drug. Travere Therapeutics shares crashed Tuesday as investors digested a delay for its drug Filspari in treating a kidney disease.The post Travere Ligand Hammered On A Surprise Delay For Their Linchpin Drug appeared first on Investor'.s Business Daily.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere Therapeutics Becomes Oversold (TVTX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Tue Jan 13, 2026

$29.11 | -14.63%

Technical

Noteworthy Tuesday Option Activity: TVTX RDDT LGND. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Travere Therapeutics Inc (Symbol: TVTX) where a total of 40965 contracts have traded so far representing approximately 4.1 million underlying shares. That amounts to

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere Therapeutics Hammered On A Potential Surprise Delay For Filspari. Travere Therapeutics shares crashed Tuesday as investors digested a potential delay for its drug Filspari in treating a kidney disease.The post Travere Therapeutics Hammered On A Potential Surprise Delay For Filspari appeared first on Investor'.s Business Daily.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Travere stock plunges after FDA requests more data on kidney drug.

Tue Jan 13, 2026

$29.11 | -14.63%

Momentum

Discover TVTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of TVTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our TVTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TVTX Stock trends

TVTX Stock performance

TVTX Stock analysis

TVTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TVTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TVTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

TVTX Stock Analysis & IQ Rating | Travere Therapeutics

TVTX Stock IQ

TVTX Target Price

TVTX Risk Level

TVTX Analysts Opinion

TVTX Street Sentiment

TVTX Performance Sentiment

Technical Price Levels

Explore our TVTX Stock insights

Receive our TVTX Daily Alerts

TVTX Street Sentiment

TVTX Risk Level

Technical Price Levels

Discover TVTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of TVTX. We're here to help you make informed investment decisions today.

Receive our TVTX Daily Alerts

TVTX Alerts